SCHEMBL7505367

SCHEMBL7505367

CN1CCN(c2ccc(Nc3ncc4ccc(=O)n(CCC(CCOc5ccccc5)Oc5ccccc5)c4n3)cc2)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 13/20 0.69
CCND1 P24385 13/20 0.69
CCND2 P30279 13/20 0.69
CCND3 P30281 13/20 0.69
CCNE2 O96020 2/20 0.56
CCNA2 P20248 2/20 0.56
CCNE1 P24864 2/20 0.56
CDK2 P24941 2/20 0.56
CCNA1 P78396 2/20 0.56
CCNB2 O95067 1/20 0.56
CDK1 P06493 1/20 0.56
FGFR1 P11362 1/20 0.56
CCNB1 P14635 1/20 0.56
FGFR2 P21802 1/20 0.56
FGFR4 P22455 1/20 0.56
FGFR3 P22607 1/20 0.56
CCNB3 Q8WWL7 1/20 0.56
JAK3 P52333 7/20 0.56
PAK4 O96013 1/20 0.52
PAK1 Q13153 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5268129 0.89 CDK4 (0.79) CDK4CCND1CCND2CCND3CCNE2
SCHEMBL5265687 0.85 CDK4 (0.68) CDK4CCND1CCND2CCND3CCNE2
SCHEMBL5267347 0.82 CDK4 (0.69) CDK4CCND1CCND2CCND3CCNE2
SCHEMBL10192690 0.81 CDK4 (0.79) CDK4CCND1CCND2CCND3CCNE2
SCHEMBL5263052 0.80 CDK4 (1.00) CDK4CCND1CCND2CCND3CCNE2
SCHEMBL5265231 0.80 CDK4 (0.68) CDK4CCND1CCND2CCND3CCNE2
SCHEMBL10192646 0.80 CDK4 (0.77) CDK4CCND1CCND2CCND3CCNE2
SCHEMBL5268660 0.79 CDK4 (0.90) CDK4CCND1CCND2CCND3CCNE2
SCHEMBL5264508 0.79 CDK4 (0.79) CDK4CCND1CCND2CCND3CCNE2
SCHEMBL5266379 0.79 CDK4 (0.75) CDK4CCND1CCND2CCND3CCNE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255755-A1 PYRIDOPYRIMIDINONE DERIVATIVES FOR TREATMENT OF NEURODEGENERATIVE DISEASE WARNER-LAMBERT COMPANY (US) 2002-11-13 EP disclosed
WO-2001055148-A1 PYRIDOPYRIMIDINONE DERIVATIVES FOR TREATMENT OF NEURODEGENERATIVE DISEASE WARNER-LAMBERT COMPANY (US) 2001-08-02 WO disclosed